前往化源商城

125-30-4

125-30-4结构式
125-30-4结构式

化源商城直购

英文名 (4R,4aR,7S,7aR,12bS)-9-ethoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol,hydrochloride
英文别名 CODETHYLINE HYDROCHLORIDE
Ethylmorphinhydrochloriddihydrat
UNII-MFM5450P3T
Ethylmorphine HCl
3-O-Ethylmorphine hydrochloride
O-Ethylmorphine hydrochloride
Dionin hydrochloride
Ethylmorphine hydrochloride
Dionine hydrochloride
EINECS 204-734-4
密度 1.31g/cm3
沸点 472.2ºC at 760mmHg
分子式 C19H24ClNO3
分子量 349.85200
闪点 239.4ºC
精确质量 349.14400
PSA 41.93000
LogP 2.63110
蒸汽压 1.01E-09mmHg at 25°C

CHEMICAL IDENTIFICATION

RTECS NUMBER :
QD0874000
CHEMICAL NAME :
Morphinan-6-alpha-ol, 7,8-didehydro-4,5-alpha-epoxy-3-ethoxy-17-methyl-, hydrochloride
CAS REGISTRY NUMBER :
125-30-4
LAST UPDATED :
199109
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C19-H23-N-O3.Cl-H

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 21,727,1971
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
771 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
APFRAD Annales Pharmaceutiques Francaises. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1943- Volume(issue)/page/year: 15,640,1957
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
265 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
APFRAD Annales Pharmaceutiques Francaises. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1943- Volume(issue)/page/year: 15,640,1957

本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。